Impact of Polycystic Ovary Syndrome on the General and Reproductive Health of Women

Authors

  • Wurood Mohamed Mutar Biology Department, College of Education, University of Samarra, Samarra, Iraq.
  • Qays Assi Ahmed Department of Biology, College of Education for Pure Sciences, Kirkuk University, Kirkuk, Iraq.
  • Ahmed Suhail Hussein Biotechnology Department, College of Applied Sciences, University of Samarra, Samarra, Iraq

Keywords:

Polycystic Ovary Syndrome (PCOS), External Factors, Internal Factors, Women Health, Reproductive

Abstract

Polycystic ovarian syndrome (PCOS) is a female endocrine condition that many women who are reproductive age experience. despite a piece of the mechanism contributory in appearance of PCOS has been find out,the precise etiology and pathogenesis aren’t well known. The extrinsic and intrinsic factors responsible for PCOS have been evaluated. Studies show a higher risk of type 2 diabetes and high blood pressure, and dyslipidemia, that this translate into an elevated risk of cardiovascular events irrespective of weight, according to current evidence. psychical health issues, Anxiety and despair are prevalent side effects that do not get enough attention, as do fatty liver disease not related to alcohol and endometrial cancer. Doubts remain about if these hazards are present in all PCOS patients or whether are they limited to certain types. and whether the risks persist after menopause. Additionally, more research is required to discover whether focused interventions and systematic screening might produce better results. Clinicians who treat women with PCOS must advice patients about long-term health concerns and develop techniques to limit illness progression and cause chronic diseases that impair women's general health until such evidence is accessible.

References

- Abbott, D.H.; A Dumesic, D.; E Levine, J. Hyperandrogenic origins of polycystic ovary syndrome – implications for pathophysiology and therapy. Expert Rev. Endocrinol. Metab. 2019, 14, 131–143.

- Akalewold, M., Yohannes, G. W., Abdo, Z. A., Hailu, Y., & Negesse, A. (2022). Magnitude of infertility and associated factors among women attending selected public hospitals in Addis Ababa, Ethiopia: a cross-sectional study. BMC Women's Health, 22(1), 1-11.‏

- Akanksha Garg, Bijal Patel, Ali Abbara, and Waljit S. Dhillo (2022). Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrom (PCOS) Clinical Endocrinology.;1–9.

- Azziz R. (2008)Polycystic ovary syndrome is a family affair. J Clin 1. Endocrinol Metab; 93:1579-1581.

- Bahri Khomami M, Joham AE, Boyle JA, et al. Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity—a systematic review, meta-analysis, and meta-regression. Obes Rev 2019; 20: 659–674.

- Balen AH. (2007), Polycystic ovary syndrome and secondary amenorrhoea.In: Edmonds DK,editor. Dewhurt's Textbook of Obstetrics & Gynaecology. 7th ed.USA: Blackwell;. P. 377-97.

- Barnard B , ; Ferriday, D. ; Guenther, N .; Strauss, B .; Balen, A,and Dye , L . (2007) . Quality of life and psychological well being in polycystic ovary syndrome. Hum . Keprod . 22(8) : 2279 - 2286 .

- Bednarska, S.; Siejka, A. The pathogenesis and treatment of polycystic ovary syndrome: What’s new? Adv. Clin. Exp. Med. 2017, 26, 359–367.

- Bohler, H. J.; Mokshagundam, S. and Winters, S. J.( 2010).Adipose tissue and reproduction in women. Fertil Steril,94,795–825.

- Brewer, C.J. and Balen, A.H.( 2010). The adverse effects of obesity on conception and implantation. Reproduction .140,347–364.

- Cai, J., Wu, C. H., Zhang, Y., Wang, Y. Y., Xu, W. D., Lin, T. C., ... & Tao, T. (2017). High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance. International Journal of Obesity, 41(9), 1341-1347.‏

- Calina, D.; Docea, A.O.; Golokhvast, K.S.; Sifakis, S.; Tsatsakis, A.; Makrigiannakis, A. Management of Endocrinopathies in Pregnancy: A Review of Current Evidence. Int. J. Environ. Res. Public Health 2019, 16, 781.

- Carrie Riestenberg, Anika Jagasia, Daniela Markovic, Richard P Buyalos, and Ricardo Azziz.(2022). Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences, The Journal of Clinical Endocrinology & Metabolism, 107, (2): 575–585.

- Casadesús, J.; Noyer-Weidner, M. Epigenetics.(2013). In Brenner’s Encyclopedia of Genetics, 2nd ed.; Maloy, S., Hughes, K., Eds.; Academic Press: San Diego, CA, USA,; pp. 500–503.

- Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod. 2016; 31: 2619- 2631.

- Chen, M. J., Chiu, H. M., Chen, C. L., Yang, W. S., Yang, Y. S., & Ho, H. N. (2010). Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 95(7), 3332-3341.‏

- Chen, T.; Wang, F.; Chu, Z.; Shi, X.; Sun, L.; Lv, H. et al. (2019) . Serum CTRP3 Levels In Obese Children: A Potential Protective Adipokine Of Obesity, Insulin Sensitivity And Pancreatic b Cell Function. Diabetes Metab Syndr Obes Targets Ther ,12,1923–30.

- Ciebiera, M.; Esfandyari, S.; Siblini, H.; Prince, L.; Elkafas, H.; Wojtyła, C.; Al-Hendy, A.; Ali, M. Nutrition in Gynecological Diseases: Current Perspectives. Nutrients 2021, 13, 1178.

- Cooney LG, Dokras A. Beyond fertility: polycystic ovary syndrome and long-term health. Fertil Steril. 2018; 110: 794- 809.

- Cortet-Rudelli, C., & Dewailly, D. (2006). Diagnosis of Hyperandrogenism in Female Adolescents. Hyperandrogenism in Adolescent Girls. Armenian Health Network, Health. am. Retrieved, 11-21.

- Damone, A.L.; Joham, A.E.; Loxton, D.; Earnest, A.; Teede, H.J.; Moran, L.J. Depression, anxiety and perceived stress in women with and without PCOS: A community-based study. Psychol. Med. 2019, 49, 1510–1520.

- Day FR, Hinds DA, Tung JY, et al. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun. 2015; 6: 8464

- Decherney, A. H and Nathan, L . (2006). Current obstetric and gynecologic diagnosis and treatment . 9th ed . MC Craw–Hill companies . PP: 99-979

- Dekkers, OM.,Thio, BH, Romijn JA,Smit JW(2006) . Acne vulgaris endocrine aspect. Ned Tijdschr Geneesked;15-30.

- Dumesic, D. A.; Abbott, D. H.; Sanchita, S.; and Chazenbalk, G. D. (2020). Endocrine-Metabolic Dysfunction in Polycystic Ovary Syndrome: an Evolutionary Perspective. Current opinion in endocrine and metabolic research, 12, 41–48.

- Dumesic, D. A.; Abbott, D. H.; Sanchita, S.; and Chazenbalk, G. D. (2020). Endocrine-Metabolic Dysfunction in Polycystic Ovary Syndrome: an Evolutionary Perspective. Current opinion in endocrine and metabolic research, 12, 41–48.

- Dunaif, A . & Thamas, A.(2001). Current conception the polycystic ovary Syndrome . Anna Rev Med .52 : 401-419.

- Ehramann, D. A. (2005) . Polycystic ovary syndrome . N. Eng .J. Med.; 352: 1223 – 36.

- Ehrmann DA, Kasza K, Azziz R, Legro RS, Ghazzi MN. PCOS/Troglitazone study group. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 90: 66- 71

- El-Mazny A,Abou-Salem N,El-Sherbiny W.(2010). Insulin resistance, dyslipidemia,and metabolic syndrome in women with polycystic ovary syndrome. Int J Gynaecol Obstet, 109:239-241.

- Faghfoori, Z.; Fazelian, S.; Shadnoush, M.; Goodarzi, R. Nutritional management in women with polycystic ovary syndrome: A review study. Diabetes Metab. Syndr. Clin. Res. Rev. 2017, 11, S429–S432.

- Falzarano, C., Lofton, T., Osei-Ntansah, A., Oliver, T., Southward, T., Stewart, S., & Andrisse, S. (2022). Nonalcoholic fatty liver disease in women and girls with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 107(1), 258-272.

- Fenichel, P.; Rougier, C.; Hieronimus, S.; Chevalier, N. (2017).Which origin for polycystic ovaries syndrome: Genetic, environmental or both? Ann. d’Endocrinol., 78, 176–185.

- Ganie, M.A.; Vasudevan, V.; Wani, I.A.; Baba, M.S.; Arif, T.; Rashid, A. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J. Med Res. 2019, 150, 333–344.

- Glueck, C.J.; Goldenberg, N. Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metab. 2019, 92, 108–120.

- Greenspan, F.S & Gardner, D.G.(2004). Basic and Clinical Endocrinology . 7th ed . Mc Graw- Hill . U.S.A. PP: 794 -796 .

- Gurnee ; Grystal , L& Illinois. (2009). Infertility with Polycystic ovaries. Advanced Fertility Center of Chicago ,S.C. all right (847) : 662-1818.

- Hanan Abdulmaged, Mohammed Oda, Mufeda Ali (2020). Effect of Body Mass Index on Serum CA125 Level in Females with PCOS , IJEIR,Vol. 10, Issue 1, Pp. 101-118.

- Ibanez, L.; Oberfield, S.E.; Witchel, S.F.; Auchus, R.J.; Chang, R.J.; Codner, E.; Dabadghao, P.; Darendeliler, F.; Elbarbary, N.; Gambineri, A.; (2017). An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm. Res. Paediatr., 88, 371–395.

- Ilie, I.R.; Georgescu, C.E.( 2015). Polycystic Ovary Syndrome-Epigenetic Mechanisms and Aberrant MicroRNA. Adv. Virus Res., 71,25–45.

- Ismayilova, M., & Yaya, S. (2022). “I felt like she didn’t take me seriously”: a multi-methods study examining patient satisfaction and experiences with polycystic ovary syndrome (PCOS) in Canada. BMC women's health, 22(1), 1-21.‏

- Jia Qi. (2018) : Local Cortisol Elevation Contributes to Endometrial Local Cortisol Elevation Contributes to Endometrial, The Journal of Clinical Endocrinology & Metabolism,103,(7): p.p 2457–2467.

- Jones, H., Sprung, V. S., Pugh, C. J., Daousi, C., Irwin, A., Aziz, N., ... & Cuthbertson, D. J. (2012). Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. The Journal of Clinical Endocrinology & Metabolism, 97(10), 3709-3716.

- Jones, L.; Regan, F. Endocrine Disrupting Chemicals. In Encyclopedia of Analytical Science, 3rd ed.; Worsfold, P., Poole, C., Townshend, A., Miró, M., Eds.; Academic Press: Oxford, UK, 2019; pp. 31–38.

- Kumarendran, B., O’Reilly, M. W., Manolopoulos, K. N., Toulis, K. A., Gokhale, K. M., Sitch, A. J., ... & Nirantharakumar, K. (2018). Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database. PLoS medicine, 15(3), e1002542.

- Li, Y.; Chen, C.; Ma, Y.; Xiao, J.; Luo, G.; Li, Y.; Wu, D. Multi-system reproductive metabolic disorder: Significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci. 2019, 228, 167–175.

- Merkin, S.S.; Phy, J.L.; Sites, C.K.; Yang, D. Environmental determinants of polycystic ovary syndrome. Fertil. Steril. 2016, 106,16–24.

- Moghetti P, Tosi F, Bonin C, et al. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2013; 98: E628- E637.

- Mukherjee, S.; Sagvekar, P.; Azarnezhad, R.; Patil, K. (2018).Pathomechanisms of polycystic ovary syndrome Multidimensional approaches. Front. Biosci., 10, 384–422.

- Muscogiuri, G.; Altieri, B.; de Angelis, C.; Palomba, S.; Pivonello, R.; Colao, A.; Orio, F. Shedding new light on female fertility: The role of vitamin D. Rev. Endocr. Metab. Disord. 2017, 18, 273–283.

- O'Reilly MW, Kempegowda P, Jenkinson C, et al. 11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome. J Clin Endocrinol Metab. 2017; 102: 840- 848

- O'Reilly MW, Kempegowda P, Walsh M, et al. AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017; 9: 3327- 3339

- Palioura, E.; Diamanti-Kandarakis, E. Industrial endocrine disruptors and polycystic ovary syndrome. J. Endocrinol. Investig. 2013, 36, 1105–1111.

- Palioura, E.; Diamanti-Kandarakis, E. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs). Rev. Endocr. Metab. Disord. 2015, 16, 365–371.

- Qu, F.; Wang, F.-F.; Yin, R.; Ding, G.-L.; El-Prince, M.; Gao, Q.; Shi, B.-W.; Pan, H.-H.; Huang, Y.-T.; Jin, M.; et al. A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: Hyperandrogenism induces epigenetic alterations in the granulosa cells. J. Mol. Med. 2012, 90, 911–923.

- Rocha, A.L.; Oliveira, F.R.; Azevedo, R.C.; Silva, V.A.; Peres, T.M.; Candido, A.L.; Gomes, K.B.; Reis, F.M. Recent advances in the understanding and management of polycystic ovary syndrome. F1000Research 2019, 8, 565.

- Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.(2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod ; 19:41

- Rutkowska, A.; Diamanti-Kandarakis, E. Polycystic ovary syndrome and environmental toxins. Fertil. Steril. 2016, 106, 948–958.

- Soave, I.; Occhiali, T.; Assorgi, C.; Marci, R.; Caserta, D. Environmental toxin exposure in polycystic ovary syndrome women and possible ovarian neoplastic repercussion. Curr. Med Res. Opin. 2020, 36, 693–703.

- Sobolewski, M.; Barrett, E.S. Polycystic Ovary Syndrome: Do Endocrine-Disrupting Chemicals Play a Role? Semin. Reprod. Med. 2014, 32, 166–176.

- Steegers-Theunissen, R.; Wiegel, R.; Jansen, P.; Laven, J.; Sinclair, K. Polycystic Ovary Syndrome: A Brain Disorder Characterized by Eating Problems Originating during Puberty and Adolescence. Int. J. Mol. Sci. 2020, 21, 8211.

- Stefanaki, C.; Pervanidou, P.; Boschiero, D.; Chrousos, G.P. Chronic stress and body composition disorders: Implications for health and disease. Hormones 2018, 17, 33–43.

- Szczuko, M.; Kikut, J.; Szczuko, U.; Szydłowska, I.; Nawrocka-Rutkowska, J.; Zi˛etek, M.; Verbanac, D.; Saso, L. Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review. Nutrients 2021, 13, 2452.

- Taha, M.K.;AL- Mahdaoui,Z.M.;Muhsen, S.N. (2022) Physiological and immune role For adipose tissue and kinetics adipose and thyroid gland functions In women with the syndrome Polycystic ovary. PhD thesis.

- Teede, H.J.; Misso, M.L.; Costello, M.F.; Dokras, A.; Laven, J.; Moran ,L., et al. (2018).Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod ,33,1602–1618.

- Tiantian Zhu & Mark Goodarzi, (2022). Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization, The Journal of Clinical Endocrinology & Metabolism, 107,(3):e899–e911.

- Tietz (2006), Textbook of Clinical Chemistry and Molecular Diagnostics, 4th Edition, Elsevier Saunders Publishers, pp2021-2027.

- Unluhizarci K, Karaca Z, Kelestimur F. Role of insulin and insulin resistance in androgen excess disorders. Word J Diabetes. 2021; 12: 616- 629.

- Varma, S. H., Tirupati, S., Pradeep, T. V. S., Sarathi, V., & Kumar, D. (2019). Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(2), 1065-1069.‏

- Vassilatou, E., Lafoyianni, S., Vryonidou, A., Ioannidis, D., Kosma, L., Katsoulis, K., ... & Tzavara, I. (2010). Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. Human reproduction, 25(1), 212-220.‏‏‏

- Wang, J.; Wu, D.; Guo, H.; Li, M. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sci. 2019, 236, 116940.

- WHO (2021). Infertility, 4 Nov, .

- Witchel, S.F.; Burghard, A.C.; Tao, R.H.; Oberfield, S.E. The diagnosis and treatment of PCOS in adolescents. Curr. Opin. Pediatr. 2019, 31, 562–569.

- Witchel, S.F.; E Oberfield, S.; Peña, A.S. Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls. J. Endocr. Soc. 2019, 3, 1545–1573.

- Wojciechowski, P.; Lipowska, A.; Rys, P.; Ewens, K.G.; Franks, S.;Tan, S. et al. (2012 ).Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis. Diabetologia .55, 2636–2645.

- Wu, J., Yao, X. Y., Shi, R. X., Liu, S. F., & Wang, X. Y. (2018). A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis. Reproductive Health, 15(1), 1-9.

- Yang, S.; Yang, C.; Pei, R.; Li, C.; Li, X.; Huang, X.; Wu, S.; Liu, D. Investigation on the association of occupational stress with risk of polycystic ovary syndrome and mediating effects of HOMA-IR. Gynecol. Endocrinol. 2018, 34, 961–964.

- Zehravi, M., Maqbool, M., & Ara, I. (2022). Polycystic ovary syndrome and infertility: an update. International Journal of Adolescent Medicine and Health, 34(2), 1-9.‏

Downloads

Published

2023-01-31

How to Cite

Wurood Mohamed Mutar, Qays Assi Ahmed, & Ahmed Suhail Hussein. (2023). Impact of Polycystic Ovary Syndrome on the General and Reproductive Health of Women. International Journal of Scientific Trends, 2(1), 34–48. Retrieved from https://scientifictrends.org/index.php/ijst/article/view/43

Issue

Vol. 2 No. 1 (2023): IJST

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.